{"result": "(\"entity\"<|>PACIENTES<|>PERSON<|>Patients with liver disease, particularly those suffering from cirrhosis, who experience various complications and nutritional deficiencies.)\n##\n(\"entity\"<|>NUTRIENTES<|>ORGANIZATION<|>Nutrients are substances that provide nourishment essential for the maintenance of life and for growth, which are often deficient in patients with liver disease.)\n##\n(\"entity\"<|>CAQUEXIA<|>EVENT<|>Cachexia is a complex syndrome associated with an underlying illness characterized by severe body weight, muscle mass, and fat loss, often seen in patients with advanced liver disease.)\n##\n(\"entity\"<|>COLANGITIS ESCLEROSANTE<|>EVENT<|>Sclerosing cholangitis is a disease that causes scarring and inflammation of the bile ducts, which can lead to liver damage and cirrhosis.)\n##\n(\"entity\"<|>CIRROSIS BILIAR PRIMARIA<|>EVENT<|>Primary biliary cirrhosis is a chronic disease that slowly destroys the bile ducts in the liver, leading to cirrhosis.)\n##\n(\"entity\"<|>COLANGIOPATÍA AUTOINMUNE<|>EVENT<|>Autoimmune cholangiopathy is a condition where the immune system attacks the bile ducts, potentially leading to liver damage and cirrhosis.)\n##\n(\"relationship\"<|>PACIENTES<|>CIRROSIS HEPÁTICA<|>Patients are often diagnosed with cirrhosis due to various underlying conditions, including alcohol use and viral hepatitis<|>8)\n##\n(\"relationship\"<|>PACIENTES<|>MALNUTRICIÓN<|>Patients with cirrhosis frequently suffer from malnutrition due to metabolic changes and dietary restrictions<|>7)\n##\n(\"relationship\"<|>CIRROSIS HEPÁTICA<|>CAQUEXIA<|>Cirrhosis can lead to cachexia, characterized by severe weight loss and muscle wasting<|>6)\n##\n(\"relationship\"<|>CIRROSIS HEPÁTICA<|>COLANGITIS ESCLEROSANTE<|>Sclerosing cholangitis can lead to cirrhosis as it causes damage to the bile ducts<|>5)\n##\n(\"relationship\"<|>CIRROSIS HEPÁTICA<|>CIRROSIS BILIAR PRIMARIA<|>Primary biliary cirrhosis is a type of liver disease that can progress to cirrhosis<|>5)\n##\n(\"relationship\"<|>CIRROSIS HEPÁTICA<|>COLANGIOPATÍA AUTOINMUNE<|>Autoimmune cholangiopathy can result in cirrhosis due to ongoing inflammation and damage to the liver<|>5)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: combina datos clínicos                       en la cirrosis hepática12, 13. Es un predictor indepen-\n(ascitis y encefalopatía hepática) con datos analíticos                      diente de complicaciones14.\n(bilirrubina, albúmina y tiempo de protrombina), clasi-                         Las deficiencias nutricionales son muy frecuentes en\nficando a los pacientes en estadio A (5-6 puntos), B                         la cirrosis avanzada, debido a una amplia variedad de\n(7-9 puntos) y C (10-15 puntos). En la clasificación ori-                    alteraciones metabólicas asociadas con la enfermedad.\nginal de Child-Turcotte, el estado nutricional estaba                        La malnutrición tiene un impacto negativo sobre el\nincluido como criterio de clasificación. Pese a ser un                       desenlace de estos pacientes, que es particularmente\nfactor pronóstico importante, no se incluyó posterior-                       relevante para aquellos que son candidatos a trasplan-\nmente en la modificación de Child-Pugh.                                      te de hígado.\n---\n 272      BLOQUE: PROTEÍNAS Y AMINOÁCIDOS\n\n\n\n6.   Prevalencia de la malnutrición                                      La leptina es una hormona producida por los adipo-\n   Es difícil estimar la prevalencia de malnutrición en               citos. Sus niveles circulantes se correlacionan estrecha-\npacientes con EHC, ya que no se dispone de patrón                     mente con la masa grasa corporal. Disminuye el apeti-\npara su evaluación y cuantificación. En pacientes con                 to, la ingesta y aumenta el gasto metabólico. Parece\nenfermedad hepática avanzada y caquexia, el diagnós-                  estar relacionada con la anorexia que presentan estos\n                                                                      pacientes34. Sus niveles están aumentados en pacientes\ntico de malnutrición es obvio. Sin embargo, en esta-                  con etilismo activo, independientemente de la presen-\ndios iniciales y pacientes bien compensados puede ser                 cia o no de cirrosis y de la masa grasa35. Sus niveles\nmás difícil decidir si un paciente está malnutrido y en               tienden a aumentar a medida que empeora la función\nqué grado. Se describe entre un 13% y un 100% de los                  hepática en pacientes con hepatitis viral y cirrosis post-\npacientes15-17. La prevalencia descrita depende de la                 hepatitis36, aunque este dato no ha sido confirmado\netiología, severidad y tipo de enfermedad hepática, así               por otros estudios37, 38. La fracción unida a proteínas\ncomo del método de valoración nutricional utilizado.                  puede ser un marcador de gasto metabólico alterado\nEstimada por antropometría, se describe entre el 20%\ny el 75%18-20. Si en la estimación se incluyen proteínas              en pacientes cirróticos39.\n\nviscerales y parámetros inmunológicos la prevalencia es                  Durante los episodios de hospitalización por compli-\nmayor21. En comparación con pacientes ingresados                      caciones de la enfermedad hepática, es frecuente que\ncon otras patologías, los cirróticos ingresados tienen                los pacientes estén en situación de ayuno, bien por la\nuna prevalencia de malnutrición cuatro veces mayor22.                 propia complicación, bien para realizar algunas prue-\nEs más prevalente en pacientes hospitalizados con en-                 bas diagnósticas.\nfermedad de origen alcohólico23. Cuanto más avanza-                      Los pacientes con etilismo frecuentemente hacen\nda está la enfermedad hepática, mayor es la prevalen-                 una ingesta deficiente, por el estilo de vida asociado a\ncia   de    malnutrición24.      En   candidatos       a  trasplante  la adicción.\nhepático, la prevalencia de malnutrición llega a alcan-\nzar el 100%25-27.                                                     7.2.    Malabsorción o maldigestión de nutrientes\n                                                                         En pacientes con enfermedad hepática con colesta-\n7. Mecanismos de malnutrición                                         sis, tales como colangitis esclerosante, cirrosis biliar\n   Nuestra comprensión de los procesos metabólicos                    primaria o colangiopatía autoinmune, es frecuente la\n                                                                      maladigestión y malabsorción40, con déficit asociado\nque acontecen en la cirrosis es limitada, aunque está                 de vitaminas liposolubles. La insuficiencia pancreática\naumentando en los últimos años.                                       exocrina puede contribuir a esta malabsorción en pa-\n   La etiología de la malnutrición en pacientes con en-               cientes alcohólicos con pancreatitis crónica. Además,\nfermedad hepática crónica es múltiple. Desde un pun-                  la hipertensión portal puede ser causa de malabsor-\nto de vista fisiopatológico se pueden considerar tres                 ción, y el control de la misma podría mejorar el estado\ncategorías de factores\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>CIRROSIS HEPÁTICA<|>EVENT<|>Cirrhosis is a chronic liver disease characterized by the replacement of healthy liver tissue with scar tissue, leading to liver dysfunction and various complications.)\n##\n(\"entity\"<|>MALNUTRICIÓN<|>EVENT<|>Malnutrition is a condition that occurs when the body does not get enough nutrients, which is prevalent in patients with advanced liver disease, particularly cirrhosis.)\n##\n(\"entity\"<|>HÍGADO<|>ORGANIZATION<|>The liver is a vital organ that processes nutrients, detoxifies harmful substances, and produces bile for digestion, significantly affected in cirrhosis.)\n##\n(\"entity\"<|>ETILISMO<|>EVENT<|>Etilismo refers to chronic alcohol consumption, which is a significant risk factor for developing liver diseases, including cirrhosis.)\n##\n(\"entity\"<|>HEPATITIS VIRAL<|>EVENT<|>Viral hepatitis is an inflammation of the liver caused by viral infections, which can lead to cirrhosis in chronic cases.)\n##\n(\"entity\"<|>TRASPLANTE HEPÁTICO<|>EVENT<|>Liver transplantation is a surgical procedure to replace a diseased liver with a healthy one, often necessary for patients with end-stage liver disease.)\n##\n(\"relationship\"<|>CIRROSIS HEPÁTICA<|>MALNUTRICIÓN<|>Cirrhosis leads to malnutrition due to metabolic alterations and dietary deficiencies associated with liver dysfunction<|>8)\n##\n(\"relationship\"<|>CIRROSIS HEPÁTICA<|>HÍGADO<|>Cirrhosis is a disease that directly affects the liver, leading to its dysfunction and complications<|>9)\n##\n(\"relationship\"<|>ETILISMO<|>CIRROSIS HEPÁTICA<|>Chronic alcohol consumption (etilismo) is a major cause of cirrhosis<|>7)\n##\n(\"relationship\"<|>HEPATITIS VIRAL<|>CIRROSIS HEPÁTICA<|>Chronic viral hepatitis can progress to cirrhosis if left untreated<|>6)\n##\n(\"relationship\"<|>CIRROSIS HEPÁTICA<|>TRASPLANTE HEPÁTICO<|>Patients with end-stage cirrhosis often require a liver transplant for survival<|>9)\n<|COMPLETE|>"}]}